Document Detail


Use of antiplatelet agents and anticoagulants in post-myocardial infarction.
MedLine Citation:
PMID:  7805079     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
This article addresses the efficacy and safety of antiplatelet and anticoagulant agents following acute myocardial infarction. Major trials are reviewed for both of these treatment modalities in the order in which they were published. Accompanying editorial comments highlight the key findings of the studies and places them in historical context. Current recommendations for treatment are summarized. Antithrombotic therapy used as an adjuvant to thrombolytic therapy is discussed elsewhere.
Authors:
L D Fiore; D Deykin
Related Documents :
18594479 - Will warfarin soon be passé? new approaches to stroke prevention in atrial fibrillation.
17938179 - Failure of current cefepime breakpoints to predict clinical outcomes of bacteremia caus...
12508189 - Coronary angiography in the fully anticoagulated patient: the transradial route is succ...
14760209 - Physicians' attitudes and the use of oral anticoagulants: surveying the present and env...
12758149 - Recombinant human c1-inhibitor produced in pichia pastoris has the same inhibitory capa...
16232019 - Safety of outpatient dalteparin therapy in veterans with mechanical heart valves.
3315739 - Early loss of myocardial myoglobin detected immunohistochemically following occlusion o...
1575129 - The relationship between 1-year mortality and infarct location in patients with non-q w...
1525809 - St segment alternans during coronary angioplasty.
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Review    
Journal Detail:
Title:  Cardiology clinics     Volume:  12     ISSN:  0733-8651     ISO Abbreviation:  Cardiol Clin     Publication Date:  1994 Aug 
Date Detail:
Created Date:  1995-01-31     Completed Date:  1995-01-31     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8300331     Medline TA:  Cardiol Clin     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  451-76     Citation Subset:  IM    
Affiliation:
Boston University School of Medicine, Massachusetts.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anticoagulants / administration & dosage,  therapeutic use*
Clinical Trials as Topic
Humans
Myocardial Infarction / drug therapy*
Platelet Aggregation Inhibitors / administration & dosage,  therapeutic use*
Research Design
Chemical
Reg. No./Substance:
0/Anticoagulants; 0/Platelet Aggregation Inhibitors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Aspirin in the primary prevention of cardiovascular disease.
Next Document:  Preventing systemic embolism in patients with abnormal ventricular function.